Walleye Trading’s Abeona Therapeutics ABEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-36
Closed -$2K 4183
2019
Q3
$2K Sell
36
-240
-87% -$18K ﹤0.01% 3926
2019
Q2
$33K Sell
276
-80
-22% -$13.4K ﹤0.01% 3652
2019
Q1
$66K Buy
+356
New +$63.7K ﹤0.01% 3630
2018
Q4
Sell
-356
Closed -$114K 4536
2018
Q3
$114K Sell
356
-2,824
-89% -$1M ﹤0.01% 4138
2018
Q2
$1.27M Buy
+3,180
New +$1.39M 0.01% 1833
2018
Q1
Sell
-444
Closed -$176 4425
2017
Q4
$176 Buy
+444
New +$184K ﹤0.01% 3531

Other funds holding ABEO

Walleye Trading's ABEO Position: Q4 2019 in Review

Walleye Trading sold out of Abeona Therapeutics (ABEO) in Q4 2019, closing a stake of 1,609 shares — an estimated $91K sold.

Walleye Trading first reported a position in ABEO in Q3 2015 and held it in 3 quarters. The position peaked at $269K in Q2 2019. 87 funds tracked by Wall St. Rank hold ABEO as of Q4 2019.

  • Walleye Trading reported no remaining Abeona Therapeutics position as of Q4 2019 after selling out during the quarter.
  • Walleye Trading sold 1,609 Abeona Therapeutics shares in Q4 2019, an estimated $91K.
  • Walleye Trading first reported a position in Abeona Therapeutics in Q3 2015 and held it in 3 quarters.
  • Walleye Trading's Abeona Therapeutics position peaked at $269K in Q2 2019.
  • 87 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q4 2019.

Based on Walleye Trading's 13F filing for Q4 2019, filed 14 Feb 2020.